Have you or your loved ones been diagnosed with acquired immune deficiency syndrome (aids)?

You may be eligible to participate in a acquired immune deficiency syndrome (aids) clinical trial.

Have you or your loved ones been diagnosed with acquired immune deficiency syndrome (aids)? You may be eligible to participate in a acquired immune deficiency syndrome (aids) clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Acquired Immune Deficiency Syndrome (AIDS) Clinical Trial
NCT02016924 | Phase 2 phase 3 | Interventional
Gilead Sciences
Sponsored by
Gilead Sciences

Have you or your loved ones been diagnosed with acquired immune deficiency syndrome (aids)?

You may be eligible to participate in a acquired immune deficiency syndrome (aids) clinical trial.

Have you or your loved ones been diagnosed with acquired immune deficiency syndrome (aids)? You may be eligible to participate in a acquired immune deficiency syndrome (aids) clinical trial.

Recruiting

Male & Female

4 - 17

Years old

This study is looking to recruit 130 Participants

The goal of this clinical study is to learn more about the safety and dosing of study drugs, cobicistat-boosted Atazanavir (ATV/co), cobicistat-boosted darunavir (DRV/co) and emtricitabine/tenofovir alafenamide (F/TAF), in children (age ≥ 4 weeks to < 18 years) with HIV.